SGMO vs WBD · rev $57.8M vs rev $39.32B
Sangamo Therapeutics Inc (SGMO) versus Warner Bros Discovery Inc (WBD) — a side-by-side from cached financials, not a winner call.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Warner Bros Discovery Inc (WBD) is a entertainment company listed on NASDAQ.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
Latest reported WBD revenue for 2024-12-31 was $39.32B. Net income was -$11.48B. Revenue was down 4.8% from 2023-12-31 to 2024-12-31. WBD currently screens at market cap $66.93B.
SGMO currently screens at market cap $74.6M. WBD currently screens at market cap $66.93B.
Not investment advice. Open the SGMO and WBD stock pages for the full models.
Not investment advice.